International Clinical Trials Registry Platform

International Clinical Trials Registry Platform
Name	International Clinical Trials Registry Platform
Formation	2005
Founder	World Health Organization
Type	Intergovernmental organization initiative
Location	Geneva
Region served	Global
Parent organization	World Health Organization

International Clinical Trials Registry Platform is an initiative established to ensure that information about clinical trials is publicly accessible, coordinated, and standardized across global registries. It was launched to improve transparency in clinical research and to counter selective reporting by linking trial registries from diverse jurisdictions and institutions. The platform interfaces with multiple stakeholders including World Health Organization, Food and Drug Administration, European Medicines Agency, and multinational research networks.

Overview

The platform acts as a coordinating framework bringing together registries such as ClinicalTrials.gov, ISRCTN Registry, Australian New Zealand Clinical Trials Registry, Japanese Primary Registries Network, and Chinese Clinical Trial Registry while interacting with entities like National Institutes of Health, European Commission, Wellcome Trust, Bill & Melinda Gates Foundation, and GAVI. It emphasizes harmonization with standards promoted by organizations such as International Committee of Medical Journal Editors, COCHRANE Collaboration, Pan American Health Organization, and UNICEF. The initiative operates within the institutional ecosystem that includes World Bank, United Nations, G7 Summit health agendas, and national agencies like Health Canada and Medicines and Healthcare products Regulatory Agency.

Purpose and Objectives

Primary objectives include promoting trial registration by sponsors such as Pfizer, GlaxoSmithKline, Novartis, Roche, and academic centers like Johns Hopkins University, Harvard Medical School, and Oxford University. It seeks to reduce publication bias highlighted by analyses from The Lancet, New England Journal of Medicine, and BMJ. The platform supports policies advocated by forums like Global Health Cluster, World Economic Forum, International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, and regional regulators including European Medicines Agency and Pharmaceuticals and Medical Devices Agency. It also aligns with ethical norms from Nuremberg Code, Declaration of Helsinki, and guidance from Council for International Organizations of Medical Sciences.

History and Development

The initiative arose after calls for transparency following controversies involving trials covered by The Lancet, Journal of the American Medical Association, and regulatory reactions by Food and Drug Administration and European Commission. Early development involved collaborations with registries such as ClinicalTrials.gov established by National Library of Medicine, ISRCTN Registry managed by Current Controlled Trials, and regional partners like Clinical Trials Registry - India, Pan African Clinical Trials Registry, and Brazilian Clinical Trials Registry. Milestones include integration with data standards influenced by International Organization for Standardization, dialogues at meetings hosted at World Health Assembly, and endorsements by funders including Wellcome Trust and United Kingdom Research and Innovation.

Registry Criteria and Data Standards

The platform sets minimum data set standards comparable to those promoted by International Committee of Medical Journal Editors and aligns with data models referenced by Health Level Seven International and Observational Health Data Sciences and Informatics. Required fields intersect with metadata conventions used by Dublin Core, and terminologies such as Medical Subject Headings and SNOMED CT. Registries must meet criteria that facilitate linkage with bibliographic databases like PubMed, Embase, and Cochrane Library, and comply with policies from Food and Drug Administration Amendments Act where applicable. Data standards enable interoperability with repositories such as European Union Clinical Trials Register and initiatives like Global Health Data Exchange.

Governance and Organization

Governance is overseen by units within World Health Organization and includes advisory input from stakeholders such as World Health Assembly delegates, representatives of European Commission, African Union, Asian Development Bank, and academic consortia like Consortium of Universities for Global Health. Technical working groups have included experts from National Institutes of Health, Centers for Disease Control and Prevention, Wellcome Trust, and regulator representatives from Medicines and Healthcare products Regulatory Agency and Pharmaceuticals and Medical Devices Agency. Partnerships extend to editorial bodies including International Committee of Medical Journal Editors and funders such as Gates Foundation.

Impact and Use in Research and Policy

The platform has informed policy changes at European Medicines Agency, influenced trial reporting practices in journals like The Lancet and New England Journal of Medicine, and aided systematic reviews conducted by Cochrane Collaboration. It underpins data used by agencies such as World Bank and United Nations Development Programme for program planning and has been cited in guidance by Pan American Health Organization and UNAIDS. Researchers from institutions including University of Oxford, Harvard University, Imperial College London, and Karolinska Institutet use registry metadata to map trial landscapes, influence regulatory submissions to bodies like Food and Drug Administration and inform clinical guidelines by organizations such as World Health Organization and National Institute for Health and Care Excellence.

Criticisms and Challenges

Critiques have noted uneven registry coverage across regions such as Sub-Saharan Africa, South Asia, and Latin America, and disparities involving sponsors including multinational corporations and academic centers. Concerns mirror debates involving ClinicalTrials.gov and journals like BMJ over selective outcome reporting and enforcement of registration policies by bodies such as International Committee of Medical Journal Editors. Technical challenges include harmonizing terminologies like SNOMED CT and integration with databases such as PubMed Central, while governance debates echo discussions at World Health Assembly and among funders like Wellcome Trust and Bill & Melinda Gates Foundation about mandates and compliance.

Category:Clinical trials Category:World Health Organization